Abstract
Bone marrow edema syndrome (BMES) is a non-traumatic clinical condition characterized by typical pattern of changes on magnetic resonance imaging (MRI). The disease rarely occurs in the forefoot region. A 37-year-old woman was diagnosed with BMES of the third metatarsal bone with typical MRI findings. She was successfully treated with iloprost infusion therapy consisted of infusion of 40 μg of iloprost in 500 ml of sodium chloride solution given over 6 h daily, for five consecutive days. In conclusion, BMES should be kept in mind, as one of the causes of severe pain of forefoot region, and iloprost seems to be an effective treatment method for BMES.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hofmann S (1999) Bone-marrow oedema in transient osteoporosis, reflex sympathetic dystrophy and osteonecrosis: differential diagnosis, cause and management. In: Jakop RP, Fulford P, Horan F (eds) European instructional course lectures EFORT, vol 4. pp 138–151
Korompilias AV, Karantanas AH, Lykissas MG, Beris AE (2009) Bone marrow edema syndrome. Skeletal Radiol 38(5):425–436
Starr AM, Wessely MA, Albastaki U, Pierre-Jerome C, Kettner NW (2008) Bone marrow edema: pathophysiology, differential diagnosis, and imaging. Acta Radiol 49(7):771–786
Aigner N, Meizer R, Stolz G et al (2003) Iloprost for the treatment of bone marrow edema in the hindfoot. Foot Ankle Clin 8:683–693
Aigner N, Petje G, Steinböck G et al. (2001) Treatment of bone marrow oedema of the talus with the prostacyclin analogue iloprost: an MRI-controlled investigation of a new method. J Bone Joint Surg [Br] 83-B:855–858
Aigner N, Petje G, Steinböck G et al (2002) Bone marrow oedema of the forefoot after chevron osteotomy: a rare cause of metatarsalgia—a case report. Foot Ankle Int 23(5):447–451
Calvo E, Alvarez L, Fernandez-Yruegas D, Vallejo C (1997) Transient osteoporosis of the foot: Bone marrow edema in 4 cases studied with MRI. Acta Orthop Scand 68:577–580
Kitaoka HB, Alexander IJ, Adelaar RS et al (1994) Clinical rating systems for the ankle-hindfoot, midfoot, hallux and lesser toes. Foot Ankle Int 15:349–353
Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG (1987) Transient regional osteoporosis. Ann Int Med 106:444–450
Fernandez-Canton G, Casado O, Capelastegui A et al (2003) Bone marrow edema syndrome of the foot: one year follow-up with MR imaging. Skletal Radiol 32:273–278
Zanetti M, Steiner CL, Seifert B, Hodler J (2002) Clinical outcome of edema-like bone marrow abnormalities of the foot. Radiology 222:184–188
Torriani M, Thomas BJ, Bredella MA, Quellette H (2008) MRI of metatarsal head subchondral fractures in patients with forefoot pain. AJR 190:570–575
Crozier F, Champsaur P, Pham T, Bartoli JM, Kasbarian M, Chagnaud C, Lafforgue P (2003) Magnetic resonance imaging in reflex sympathetic dystrophy syndrome of the foot. J Bone Spine 70:503–508
Elias I, Zoga AC, Schweitzer ME, Ballehr L, Morrison WB, Raikin SM (2007) A specific bone marrow edema around the foot and ankle following trauma and immobilization therapy: pattern description and potential clinical relevance. Foot Ankle Int 28:463–471
Arazi M, Yel M, Uguz B, Emlik D (2006) Be aware of bone marrow edema syndrome in ankle arthroscopy: a case successfully treated with Iloprost. Arthroscopy 22(8):909.e1–909.e3
Jager M, Zilkens C, Bittersohl B, Matheney T, Kozina G, Blondin D, Krauspe R (2010) Efficiency of iloprost treatment for osseous malperfusion. Int Orthop [Epub ahead of print]
Jäger M, Tillmann FP, Thornhill TS, Mahmoudi M, Blondin D, Hetzel GR, Zilkens C, Krauspe R (2008) Rationale for prostaglandin I2 in bone marrow oedema—from theory to application. Arthritis Res Ther 10(5):R120
Tillmann FP, Jäger M, Blondin D, Schooldermann D, Voiculescu A, Sucker C, Grabensee B, Krauspe R, Hetzel GR (2007) Intravenous iloprost: a new therapeutic option for patients with post-transplant distal limb syndrome (PTDLS). Am J Transplant 7:667–671
Grant SM, Goa KI (1992) Iloprost: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischemia and extracorporal circulation procedures. Drugs 43(6):889–924
Meizer R, Radda C, Stolz G et al (2005) MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue Iloprost. Wien Klin Wochenschr 117:278–286
Zanetti M, Bruder E, Romero J, Hodler J (2000) Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology 215:835–840
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arazi, M., Kiresi, D. Bone marrow edema syndrome of the third metatarsal bone: a rare cause of metatarsalgia treated with Iloprost. Eur J Orthop Surg Traumatol 21, 59–62 (2011). https://doi.org/10.1007/s00590-010-0650-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-010-0650-4